ETF overview
The Funds investment objective is to generate returns that closelyrncorrespond, before fees and expenses, generally to the price and yieldrnperformance of the Solactive Genomics v2 Index
Current price
10.50 EUR+1.35%
Close 11 Nov 2026Interval
BenchmarksFund facts
- Expense ratio
- 0.50%
- Fund assets
- 140.75M USD (all share classes)
- Issuer
- Global X
- Inception date
- Nov 2, 2021
- Number of holdings
- 51
Breakdown
Holdings (51)
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 13.56% |
| TWIST BIOSCIENCE CORP | TWST | 5.50% |
| 10X GENOMICS INC-CLASS A | TXG | 5.21% |
| GUARDANT HEALTH INC | GH | 4.99% |
| ILLUMINA INC | ILMN | 4.83% |
| NATERA INC | NTRA | 4.42% |
| QIAGEN N.V. | QIA.DE | 3.73% |
| VERTEX PHARMACEUTICALS INC | VRTX | 3.72% |
| BIO-TECHNE CORP | TECH | 3.68% |
| GENSCRIPT BIOTECH CORP | 1548.HK | 3.41% |
| and 38 more | ||
Similar ETFs
- Global X - Genomics & Biotechnology ETFGNOM · Overlap 100% · Expense ratio 0.50%
- Ark Genomic Revolution Ucits ETF AccumUSDARKG.L · Overlap 38% · Expense ratio 0.75%
- ARK Genomic Revolution ETFARKG · Overlap 38% · Expense ratio 0.75%
- iShares Genomics Immunology and Healthcare ETFIDNA · Overlap 31% · Expense ratio 0.47%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
Global X Genomics & Biotechnology UCITS ETF (GN0M.DE)
GN0M.DE · XETRA
10.50 EUR+1.35%
Sign up to track this ETFBenchmarks
Fund facts
- Expense ratio
- 0.50%
- Fund assets
- 140.75M USD (all share classes)
- Issuer
- Global X
- Inception date
- Nov 2, 2021
- Number of holdings
- 51
Breakdown
Holdings (51)
| Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 13.56% |
| TWIST BIOSCIENCE CORP | TWST | 5.50% |
| 10X GENOMICS INC-CLASS A | TXG | 5.21% |
| GUARDANT HEALTH INC | GH | 4.99% |
| ILLUMINA INC | ILMN | 4.83% |
| NATERA INC | NTRA | 4.42% |
| QIAGEN N.V. | QIA.DE | 3.73% |
| VERTEX PHARMACEUTICALS INC | VRTX | 3.72% |
| BIO-TECHNE CORP | TECH | 3.68% |
| GENSCRIPT BIOTECH CORP | 1548.HK | 3.41% |
| and 38 more | ||
ETF overview
The Funds investment objective is to generate returns that closelyrncorrespond, before fees and expenses, generally to the price and yieldrnperformance of the Solactive Genomics v2 Index
- Global X - Genomics & Biotechnology ETFGNOM · Overlap 100% · Expense ratio 0.50%
- Ark Genomic Revolution Ucits ETF AccumUSDARKG.L · Overlap 38% · Expense ratio 0.75%
- ARK Genomic Revolution ETFARKG · Overlap 38% · Expense ratio 0.75%
- iShares Genomics Immunology and Healthcare ETFIDNA · Overlap 31% · Expense ratio 0.47%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free